Evidence map›Paper›PMID 24128970›Full record

ReviewBiochimica et biophysica acta2014

Lipid abnormalities and lipid-based repair strategies in atopic dermatitis.

Peter M Elias

Registry-linked trialAbstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03089476 (Hypothesis), which is not on this map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03089476 nawithdrawnnot on this mapstarted 2017, after this paper: background citation

Hypothesis: Skin Barrier Dysfunction With Altered Expression of Skin Barrier Proteins and Lipids Predicts Early Food Sensitizations in Infants at High Risk of Atopy

TypeinterventionalSponsorNational Jewish HealthRan2017 to 2018Enrolled0ConditionsAtopic Dermatitis, Eczema, Food AllergyArmsEvaluating atopy in infants, Evaluating TEWL and STS in adults
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Emollients and moisturisers for eczema.The Cochrane database of systematic reviews · 2017
    Pooled it
  3. Trial
  4. Therapeutic responses toScience translational medicine · 2020
    Trial
  5. Trial
  6. Review
  7. The Role of Ceramides in Metabolic and Cardiovascular Diseases.Journal of cardiovascular development and disease · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Imaging-based evaluation of lipids in the stratum corneum by label-free stimulated Raman scattering microscopy.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. On the surface: Skin microbial exposure contributes to allergic disease.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2020
    Review
  17. Article
  18. Non-invasive imaging in dermatology and the unique potential of raster-scan optoacoustic mesoscopy.Journal of the European Academy of Dermatology and Venereology : JEADV · 2019
    Review
  19. Epithelial barrier repair and prevention of allergy.The Journal of clinical investigation · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Peter M EliasDermatology Service, Veterans Affairs Medical Center, and Department of Dermatology, University of California, San Francisco, CA, USA. Electronic address: eliasp@derm.ucsf.edu.
San Francisco VA Medical Center · US

Funding

NATURE OF THE MAMMALIAN CUTANEOUS PERMEABILITY BARRIERR01AR019098 · NIAMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ELIAS, PETER M · 1986 to 2012
$4.2M
NIAMS NIH HHS AR019098NIAMS NIH HHS R01 AR019098
6 · The paper itself

Abstract

Prior studies have revealed the key roles played by Th1/Th2 cell dysregulation, IgE production, mast cell hyperactivity, and dendritic cell signaling in the evolution of the chronic, pruritic, inflammatory dermatosis that characterizes atopic dermatitis (AD). We review here increasing evidence that the inflammation in AD results primarily from inherited abnormalities in epidermal structural and enzymatic proteins that impact permeability barrier function. We also will show that the barrier defect can be attributed to a paracellular abnormality due to a variety of abnormalities in lipid composition, transport and extracellular organization. Accordingly, we also review the therapeutic implications of this emerging pathogenic paradigm, including several current and potentially novel, lipid-based approaches to corrective therapy. This article is part of a Special Issue entitled The Important Role of Lipids in the Epidermis and their Role in the Formation and Maintenance of the Cutaneous Barrier. Guest Editors: Kenneth R. Feingold and Peter Elias.

Indexed as

AnimalsBiological Transport, ActiveDermatitis, AtopicEpidermisFilaggrin ProteinsHumansImmunoglobulin ELipid MetabolismLipidsMast CellsTh1 CellsTh2 CellsFilaggrin ProteinsFLG protein, humanImmunoglobulin ELipidsAntimicrobial peptideAtopic dermatitisBarrier functionFilaggrinpHSerine protease inhibitor

Identifiers

PMID24128970
PMCPMC3943491
OpenAlexW2131312858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.